Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1 H -pyrazol-1′-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid) A Receptor
The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.
Abstract
Certain classes of neuroactive steroids (NASs) are positive allosteric modulators (PAM) of synaptic and extrasynaptic GABA A receptors. Herein, we report new SAR insights in a series of 5β-nor-19-pregnan-20-one analogues bearing substituted pyrazoles and triazoles at C-21, culminating in the discovery of 3α-hydroxy-3β-methyl-21-(4-cyano-1 H -pyrazol-1′-yl)-19-nor-5β-pregnan-20-one (SAGE-217, 3 ), a potent GABA A receptor modulator at both synaptic and extrasynaptic receptor subtypes, with excellent oral DMPK properties. Compound 3 has completed a phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) clinical trial and is currently being studied in parallel phase 2 clinical trials for the treatment of postpartum depression (PPD), major depressive disorder (MDD), and essential tremor (ET).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NAS GABAAR PAMs have pharmacological profiles and binding sites distinct from benzodiazepines,40,41 with the ability to modulate the activity of both synaptic and extrasynaptic GABAARs.39,42”
From Effect of Zuranolone vs Placebo in Postpartum Depression (2021) · cites this paper as [42]
Citations
Cites
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225
The GABAergic deficit hypothesis of major depressive disorder
Luscher, B., Shen, Q., & Sahir, N. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.120 · Cited by 934
Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites
Hosie, A. M., Wilkins, M. E., da Silva, H. M. A., & Smart, T. G. (2006) · Nature · doi:10.1038/nature05324 · Cited by 752
Neurosteroids and GABAA receptor function
Lambert, J. J., Belelli, D., Hill-Venning, C., & Peters, J. A. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89058-6 · Cited by 746
GABAergic dysfunction in mood disorders
Brambilla, P., Perez, J., Barale, F., Schettini, G., & Soares, J. C. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001362 · Cited by 553
GABA-based therapeutic approaches: GABAA receptor subtype functions
RUDOLPH, U., & MOHLER, H. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.10.003 · Cited by 499
Extrasynaptic GABA A Receptors: Form, Pharmacology, and Function
Belelli, D., Harrison, N. L., Maguire, J., Macdonald, R. L., Walker, M. C., & Cope, D. W. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3340-09.2009 · Cited by 464
A single histidine in GABAA receptors is essential for benzodiazepine agonist binding.
Wieland, H. A., Lüddens, H., & Seeburg, P. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45961-3 · Cited by 447
Impact of solid state properties on developability assessment of drug candidates
Huang, L. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.007 · Cited by 438
Subunit-Specific Trafficking of GABAAReceptors during Status Epilepticus
Goodkin, H. P., Joshi, S., Mtchedlishvili, Z., Brar, J., & Kapur, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3426-07.2008 · Cited by 322
Neurosteroid binding sites on GABAA receptors
Hosie, A. M., Wilkins, M. E., & Smart, T. G. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.03.011 · Cited by 218
Neurosteroids, stress and depression: Potential therapeutic opportunities
Zorumski, C. F., Paul, S. M., Izumi, Y., Covey, D. F., & Mennerick, S. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.10.005 · Cited by 194
Progress report on new antiepileptic drugs: A summary of the Twelfth Eilat Conference (EILAT XII)
Bialer, M., Johannessen, S. I., Levy, R. H., Perucca, E., Tomson, T., & White, H. S. (2015) · Epilepsy Research · doi:10.1016/j.eplepsyres.2015.01.001 · Cited by 174
Maruoka, K., Itoh, T., & Yamamoto, H. (1985) · Journal of the American Chemical Society · doi:10.1021/ja00301a048 · Cited by 169
Neuroactive steroids for the treatment of status epilepticus
Rogawski, M. A., Loya, C. M., Reddy, K., Żółkowska, D., & Lossin, C. (2013) · Epilepsia · doi:10.1111/epi.12289 · Cited by 160
Self-citationOpen-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression
Kanes, S. J., Colquhoun, H., Doherty, J., Raines, S., Hoffmann, E., Rubinow, D. R., & Meltzer-Brody, S. (2017) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2576 · Cited by 151
Self-citationNeurosteroids promote phosphorylation and membrane insertion of extrasynaptic GABA A receptors
Abramian, A. M., Comenencia-Ortiz, E., Modgil, A., Vien, T. N., Nakamura, Y., Moore, Y. E., Maguire, J. L., Terunuma, M., Davies, P. A., & Moss, S. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403285111 · Cited by 115
Αmin, J., Brooks‐Kayal, A. R., & Weiss, D. S. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.5.833 · Cited by 113
Bialer, M., Johannessen, S. I., Levy, R. H., Perucca, E., Tomson, T., & White, H. S. (2017) · Epilepsia · doi:10.1111/epi.13634 · Cited by 110
Differentiating the role of γ-aminobutyric acid type A (GABAA) receptor subtypes
Wafford, K. A., Macaulay, A. J., Fradley, R., O'Meara, G. F., Reynolds, D. S., & Rosahl, T. W. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320553 · Cited by 61
Botella, G. M., Salituro, F. G., Harrison, B. L., Beresis, R. T., Bai, Z., Shen, K., Belfort, G. M., Loya, C. M., Ackley, M. A., Grossman, S. J., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00032 · Cited by 57
Self-citationGee, K. W. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-5347(25)00374-x · Cited by 45
Anticonvulsant profile of the neuroactive steroid, SGE-516, in animal models
Hammond, R., Althaus, A. L., Ackley, M. A., Maciag, C. M., Botella, G. M., Salituro, F. G., Robichaud, A. J., & Doherty, J. (2017) · Epilepsy Research · doi:10.1016/j.eplepsyres.2017.05.001 · Cited by 24
Self-citationNatural and Synthetic Neuroactive Steroid Modulators of GABAA and NMDA Receptors
Martínez-Botella, G., Ackley, M. A., Salituro, F. G., & Doherty, J. (2014) · Annual reports in medicinal chemistry · doi:10.1016/b978-0-12-800167-7.00003-1 · Cited by 13
Self-citationExploratory Trial Results for SAGE-547 in Essential Tremor (P4.297)
Ellenbogen, A. L., Raines, S. R., & Kanes, S. (2016) · Neurology · doi:10.1212/wnl.86.16_supplement.p4.297 · Cited by 5
Research works printed but not linked: 1
- 10.1016/j.eplepsyres.2015.01.001 · DOI · Paper page
Cited by
Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond
Zorumski, C. F., Paul, S. M., Covey, D. F., & Mennerick, S. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100196 · Cited by 305
Effect of Zuranolone vs Placebo in Postpartum Depression
Deligiannidis, K. M., Meltzer-Brody, S., Gunduz-Bruce, H., Doherty, J., Jonas, J., Li, S., Sankoh, A. J., Silber, C., Campbell, A. D., Werneburg, B., et al. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.1559 · Cited by 277
Self-citationBipolar depression: a major unsolved challenge
Baldessarini, R. J., Vázquez, G. H., & Tondo, L. (2020) · International Journal of Bipolar Disorders · doi:10.1186/s40345-019-0160-1 · Cited by 235
Trial of SAGE-217 in Patients with Major Depressive Disorder
Gunduz-Bruce, H., Silber, C., Kaul, I., Rothschild, A. J., Riesenberg, R., Sankoh, A. J., Li, H., Lasser, R., Zorumski, C. F., Rubinow, D. R., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1815981 · Cited by 232
Self-citationWhere Do Recent Small Molecule Clinical Development Candidates Come From?
Brown, D. G., & Boström, J. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00675 · Cited by 176
Metadata
- Authors
- Martinez Botella, G., Salituro, F. G., Harrison, B. L., Beresis, R. T., Bai, Z., Blanco, M.-J., Belfort, G. M., Dai, J., Loya, C. M., Ackley, M. A., Althaus, A. L., Grossman, S. J., Hoffmann, E., Doherty, J. J., & Robichaud, A. J.
- Affiliations
- Sage Therapeutics, Inc. 215 First Street, Cambridge, Massachusetts 02142, United States
- Sage Therapeutics (United States) (US)
- Shanghai Chempartner, 998 Halei Road, Shanghai 201203, China
- WuXi AppTec (China) (CN)
- Corresponding author
- Salituro, Francesco G.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-08-17
- Volume
- 60
- Issue
- 18
- Pages
- 7810-7819
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2740680044
- Cited by
- 129
- References
- 26
- Citations by year
- 2026: 11 · 2025: 11 · 2024: 24 · 2023: 21 · 2022: 9 · 2021: 16 · 2020: 16 · 2019: 12 · 2018: 8 · 2017: 1
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Keywords
- neurosteroids, GABAA receptor, positive allosteric modulators, structure-activity relationship, extrasynaptic GABAA receptors, oral bioavailability, pharmacokinetics, postpartum depression, major depressive disorder, essential tremor
- MeSH terms
- Allosteric Regulation, Animals, Depressive Disorder, Major, Major Depressive Disorder, Female, Pregnanolone, Pyrazoles, Receptors, GABA-A, Depression, Postpartum, Mice, Rats, GABA-A Receptor Agonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.